ING’s Stadig warns US-China biotech deals face more scrutiny and slightly fewer deals
Washington’s investment and technology-transfer restrictions are tightening, and industry analysts expect deal complexity to keep rising.
By Hessa Al-Faleh·· 3 min
1 briefing · “technology-transfer”
Washington’s investment and technology-transfer restrictions are tightening, and industry analysts expect deal complexity to keep rising.